Thomas Henry Glocer
Independent Lead DirectorMr. Thomas Henry Glocer, J.D., also known as Tom, serves as Non-Executive Director at Informa plc since October 1, 2026. He is Independent Lead Director of Merck Sharp & Dohme LLC and serves as its Director since 2007. He is Member of Legal & Regulatory Advisory Board of Nomos AI, Inc. He is Investor of Alchemy Ventures. Mr. Glocer is Independent Director of Publicis Groupe S.A. from May 29, 2024. Mr. Glocer served as Member of Advisory Board at Afiniti Inc. He is Co-Founder and Vice Chairman of the Board at Bluevoyant LLC. He was Executive Chairman of the Board at Bluevoyant LLC. He is a Director at Reynen Court LLC. He serves as Independent Lead Director at Merck & Co., Inc. since September 29, 2021. He was Member of Supervisory Board at Publicis Groupe SA since May 25, 2016 until May 29, 2024. Mr. Glocer is a General Partner and a Co-Founder of Communitas Capital Partners LLC. Mr. Glocer was the Partner since October 2018 and a Co-Founder of Communitas Capital Partners LLC since January 2017. He has been Strategy Adviser and Member of Advisory Board at PQ Solutions Limited since September 2016. He is Co-Founder & Executive Chairman of Capitolis, Inc. fsince June 2017. He is a Member of the Advisory Committee of Columbia Global Center, Paris (United States). He is Member of the International Advisory Group of Linklaters LLP (United Kingdom). Mr. Glocer focus on business development as Post-Quantum builds out its modular product suite to counter the growing cyber-security threat to the finance, government and healthcare verticals. Mr. Glocer is the Founder, Managing Director and Managing Partner at Angelic Ventures, LP since January 2012. He serves as an Advisor of HomerLearning, Inc. He serves as a Co-Founder of Blueteam Global (formerly known as BlueVoyant). Mr. Glocer served as an Advisor of American Prison Data Systems, PBC. Mr. Glocer served as the Chief Executive Officer of Thomson Reuters UK Limited from July 2001 to January 1, 2012. He served as Chief Executive Officer of Reuters Group Plc from 2001 to January 2012. He served as the Chief Executive Officer of Thomson Reuters Corporation from April 2008 to January 1, 2012. He joined Reuters Group Plc in 1993 and served as its Vice President and Deputy Counsel of Reuters America and served as an Executive Vice President and General Counsel, Reuters America Holdings since 1995. Mr. Glocer worked the Chief Executive Officer of Reuters Information Division from January 2000 to January 2001. Mr. Glocer was Technical Director of the NSA and Rebecca Bace, NSA Research Leader and experienced Tech Investor with Trident Capital. Before joining Reuters Group PLC in 1993, he was a mergers and acquisitions lawyer with Davis Polk & Wardwell from 1984 to 1993. He served as an Executive Director of Thomson Reuters Corporation and Thomson Reuters UK Limited from June 2000 to December 31, 2012. He served as an Executive Director of Reuters Group Plc from June 2000 to December 2011. Mr. Glocer served as Senior Director of Instinet Group, LLC since May 2001. He has business start-up experience in the development of software for educational games. He has been an Independent Director of Merck & Co., Inc. since November 27, 2007. He has been a Member of Advisory Board at Kivun Hadash S.R. Software Ltd. since June 25, 2014. Mr. Glocer serves as a Trustee of the Cleveland Clinic. Mr. Glocer serves as a Member of International Business Council of the World Economic Forum. He has been a Member of Strategic Advisory Board at Cinchcast Inc. since April 30, 2013. He served as a Director of Verto Analytics Inc. since December 22, 2016 until May 2019. He has been an Independent Director of Morgan Stanley since May 14, 2013 and has been its Lead Independent Director since September 1, 2017. He has been a Member of Advisory Board at The Big Think, Inc. since May 30, 2012. He serves as a Member of Advisory Board at WorkFusion, Inc., Velocity Mobile Limited and Symphony Communication Services LLC. He served as a Member of Advisory Board of AlphaSense, Inc. He serves as a Member of the International Advisory Board at Oxford Analytica Ltd. He has been a Member of the Board of K2 Integrity Holdings, Inc. (formerly known as K2 Intelligence, LLC) since January 2012. Mr. Glocer serves as a Member of the Advisory Board of British-American Business Council, the Judge Institute of Management at Cambridge University and of the International Advisory Panel of the Monetary Authority of Singapore. He served vas a Director of the New York City Investment Fund Manager, Inc. He was Director of ADFIN Solutions, Inc. until May 2016 and Council on Foreign Relations until July 2016. He serves as a Member of the Advisory Board of Atlantic Council International, the President's Council on international activities at Yale University, Columbia University Global Center, the Social Sciences Research Council, GP Investments., the American Law Institute and ADFIN Solutions, Inc. Mr. Glocer holds Bachelors of Arts in Political Science and Government Degree in Political Philosophy from Columbia University in 1981 and a JD from Yale Law School in 1984.
Positions
- Company NameMerck & Co., Inc.Stock CodeMRKPositionIndependent Lead DirectorColleagues
- RMRobert M. DavisChairman, President & CEO
- CACaroline A. LitchfieldExecutive VP & CFO
- JLJennifer L. ZacharyExecutive VP & General Counsel
- DYDean Y. LiExecutive VP & President of Merck Research Laboratories
- DEDalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller
- PFPatricia F. RussoIndependent Director
- PJPamela J. CraigIndependent Director
- PBPaul B. RothmanIndependent Director
